The global proteomics market size was valued at USD 37.60 billion in 2024. The market is projected to be worth USD 41.97 billion in 2025 and reach USD 96.81 billion by 2032, exhibiting a CAGR of 12.7% during the forecast period. North America dominated the proteomics market with a market share of 43.69% in 2024.
The Proteomics Market ****is experiencing transformative growth, driven by healthcare technology innovations, expanding digital ecosystems, and a rising focus on preventive and personalized medicine. Between 2024 and 2032, the industry is projected to expand significantly, supported by higher healthcare budgets, evolving patient expectations, and growing investments in infrastructure and research.
Demographic shifts—including aging populations, urbanization, and the rising prevalence of chronic diseases—are further accelerating demand for advanced healthcare services and solutions worldwide.
Proteomics Market represents a broad set of products, solutions, and services that enhance care delivery, improve safety, and ensure compliance. These solutions are crucial for reducing risks, protecting patients, enhancing diagnostic and treatment efficiency, and maintaining regulatory adherence.
Continue reading for more details:
https://www.fortunebusinessinsights.com/Proteomics-Market-106940
The Proteomics Market can be segmented as follows: